Skip to main content

Blue-Light Filtering Lenses Seem Not to Be Beneficial

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Aug. 23, 2023 -- Blue-light filtering lenses, which filter ultraviolet radiation and claim to improve visual performance with digital device use, seem not to attenuate symptoms of eye strain, according to a study published online Aug. 18 in the Cochrane Database of Systematic Reviews.

Sumeer Singh, Ph.D., from the University of Melbourne in Australia, and colleagues examined the effects of blue-light filtering lenses compared to non-blue-light filtering lenses in adults in a systematic review. A total of 17 randomized controlled trials (RCTs), with sample sizes ranging from five to 156 adult participants, were included. The primary outcomes were change in visual fatigue score and critical flicker-fusion frequency (CFF).

The researchers found that at less than one week of follow-up, there was no difference in subjective visual fatigue scores with blue-light filtering versus non-blue-light filtering lenses. In one RCT, there was no difference between the intervention arms, while two studies that measured visual fatigue scores showed no significant difference between intervention arms. CFF measured at less than one day of follow-up showed little to no difference with blue-light filtering versus non-blue-light filtering lenses. No significant difference between intervention arms was reported in one study, while another showed a less negative change in CFF (indicating less visual fatigue) with high- versus low-blue-light filtering lenses and non-blue-light filtering lenses.

"Our findings do not support the prescription of blue-light filtering lenses to the general population. These results are relevant to a broad range of stakeholders, including eye care professionals, patients, researchers and the broader community," senior author Laura E. Downie, Ph.D., from the University of Melbourne, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.